生产-话题@MedSci

#生产#

189篇内容 | 3794人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1517862, encodeId=81ac151e8620b, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, objectType=article, longId=739036, objectId=f1d8e3903613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1d8e3903613, replyNumber=0, likeNumber=100, createdTime=2022-09-13, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1d8e3903613, moduleTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1d8e3903613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517860, encodeId=38fe151e860a6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=CAR-T细胞生产工艺中的关键环节有哪些？如何规模化、安全稳定的生产制备？, objectType=article, longId=735144, objectId=4b13e3514457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b13e3514457, replyNumber=0, likeNumber=140, createdTime=2022-08-09, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b13e3514457, moduleTitle=CAR-T细胞生产工艺中的关键环节有哪些？如何规模化、安全稳定的生产制备？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b13e3514457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517859, encodeId=5225151e859e5, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=Contact Dermatitis：手卫生产品选什么？肥皂，酒精还是湿巾？, objectType=article, longId=726079, objectId=771de2607949, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=771de2607949, replyNumber=0, likeNumber=138, createdTime=2022-05-05, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=771de2607949, moduleTitle=Contact Dermatitis：手卫生产品选什么？肥皂，酒精还是湿巾？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=771de2607949)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517858, encodeId=21f2151e858d4, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=丽珠V-01新冠疫苗针对老年及基础病人群保护力高达71.83%，已经生产成品约5000万剂, objectType=article, longId=723713, objectId=f135e237136b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f135e237136b, replyNumber=0, likeNumber=128, createdTime=2022-04-08, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f135e237136b, moduleTitle=丽珠V-01新冠疫苗针对老年及基础病人群保护力高达71.83%，已经生产成品约5000万剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f135e237136b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517857, encodeId=cbcb151e85763, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=亚瑟医药宣布完成数亿元人民币A轮融资，推动高端制剂研发生产及连续化生产布局，凯乘资本担任本轮融资财务顾问, objectType=article, longId=723647, objectId=ee4fe2364717, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee4fe2364717, replyNumber=0, likeNumber=134, createdTime=2022-04-08, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee4fe2364717, moduleTitle=亚瑟医药宣布完成数亿元人民币A轮融资，推动高端制剂研发生产及连续化生产布局，凯乘资本担任本轮融资财务顾问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee4fe2364717)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517861, encodeId=8c2c151e8615d, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=【Nature子刊】突破性方法——高效表达生物活性蛋白，快速生产大量药物！, objectType=article, longId=301897, objectId=c38030189e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c38030189e22, replyNumber=0, likeNumber=118, createdTime=2022-03-30, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c38030189e22, moduleTitle=【Nature子刊】突破性方法——高效表达生物活性蛋白，快速生产大量药物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c38030189e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517856, encodeId=ca86151e856fa, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=科学是第一生产力！这些buff可以帮助富含血小板血浆效果超级加倍, objectType=article, longId=295359, objectId=448c295359a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=448c295359a5, replyNumber=0, likeNumber=134, createdTime=2022-02-11, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=448c295359a5, moduleTitle=科学是第一生产力！这些buff可以帮助富含血小板血浆效果超级加倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=448c295359a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517855, encodeId=9e08151e855e4, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=Nature Chemical Biology ：疯狂的想法：武装CAR-T细胞，使其成为生产抗癌药物的“微型药房”, objectType=article, longId=293584, objectId=b5d3293584a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5d3293584a6, replyNumber=0, likeNumber=109, createdTime=2022-01-09, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5d3293584a6, moduleTitle=Nature Chemical Biology ：疯狂的想法：武装CAR-T细胞，使其成为生产抗癌药物的“微型药房”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5d3293584a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517854, encodeId=3e82151e854d9, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=2021年10月19日简报：本土又有少量病例感染；中国今年生产60亿剂疫苗，达到全球一半；混合接种加强针效果可能更好；, objectType=article, longId=218870, objectId=78b82188e0bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78b82188e0bc, replyNumber=0, likeNumber=113, createdTime=2021-10-20, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78b82188e0bc, moduleTitle=2021年10月19日简报：本土又有少量病例感染；中国今年生产60亿剂疫苗，达到全球一半；混合接种加强针效果可能更好；, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78b82188e0bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517853, encodeId=96c7151e85332, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=国药集团中国生物复诺健mRNA疫苗产业化基地开工，国内又一mRNA疫苗生产线, objectType=article, longId=217713, objectId=886f21e71368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=886f21e71368, replyNumber=0, likeNumber=116, createdTime=2021-09-28, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=886f21e71368, moduleTitle=国药集团中国生物复诺健mRNA疫苗产业化基地开工，国内又一mRNA疫苗生产线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=886f21e71368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517852, encodeId=2eb5151e852b8, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=全国药店已超56万家，药品生产企业达7000家, objectType=article, longId=214112, objectId=63fe21411208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63fe21411208, replyNumber=0, likeNumber=120, createdTime=2021-07-14, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63fe21411208, moduleTitle=全国药店已超56万家，药品生产企业达7000家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63fe21411208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517851, encodeId=6b79151e851dd, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=BioNTech将在新加坡、中国设厂生产mRNA新冠疫苗, objectType=article, longId=211118, objectId=aa5d21111858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa5d21111858, replyNumber=0, likeNumber=123, createdTime=2021-05-13, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa5d21111858, moduleTitle=BioNTech将在新加坡、中国设厂生产mRNA新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa5d21111858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517850, encodeId=f690151e85083, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=2021年5月10日全球新冠肺炎（COVID-19）疫情简报，日新增63.3万，BioNtech mRNA新冠疫苗将在国内生产和商业化, objectType=article, longId=211060, objectId=0efc211060e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0efc211060e6, replyNumber=0, likeNumber=120, createdTime=2021-05-11, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0efc211060e6, moduleTitle=2021年5月10日全球新冠肺炎（COVID-19）疫情简报，日新增63.3万，BioNtech mRNA新冠疫苗将在国内生产和商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0efc211060e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517849, encodeId=fa1f151e849cc, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=印度是全球很大的新冠疫苗生产国，却面临严重的内部短缺, objectType=article, longId=210855, objectId=01a121085519, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01a121085519, replyNumber=0, likeNumber=125, createdTime=2021-05-07, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01a121085519, moduleTitle=印度是全球很大的新冠疫苗生产国，却面临严重的内部短缺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01a121085519)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517848, encodeId=5401151e84823, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=昨日接种955万剂次！31个省（自治区、直辖市）和新疆生产建设兵团累计报告接种新冠病毒疫苗25346.3万剂次, objectType=article, longId=210698, objectId=8b302106989e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b302106989e, replyNumber=0, likeNumber=112, createdTime=2021-05-02, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b302106989e, moduleTitle=昨日接种955万剂次！31个省（自治区、直辖市）和新疆生产建设兵团累计报告接种新冠病毒疫苗25346.3万剂次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b302106989e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517847, encodeId=2962151e847cf, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=百济神州广州生物药生产基地正式启用，让中国患者享受国际品质抗癌药, objectType=article, longId=209735, objectId=3b21209e359a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b21209e359a, replyNumber=0, likeNumber=138, createdTime=2021-04-11, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b21209e359a, moduleTitle=百济神州广州生物药生产基地正式启用，让中国患者享受国际品质抗癌药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b21209e359a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517846, encodeId=e03c151e84667, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=药明生物将接管德国制药厂，用于生产新冠疫苗等, objectType=article, longId=209535, objectId=609120953548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=609120953548, replyNumber=0, likeNumber=122, createdTime=2021-04-05, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=609120953548, moduleTitle=药明生物将接管德国制药厂，用于生产新冠疫苗等, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=609120953548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517845, encodeId=8efc151e845b3, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=寡核苷酸药物未来可期，日东电工再投资超2亿美金扩大生产, objectType=article, longId=209529, objectId=25ba2095298f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ba2095298f, replyNumber=0, likeNumber=109, createdTime=2021-04-05, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ba2095298f, moduleTitle=寡核苷酸药物未来可期，日东电工再投资超2亿美金扩大生产, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ba2095298f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517844, encodeId=472d151e844d6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=武田和IDT为强生COVID-19疫苗生产提供支持, objectType=article, longId=208551, objectId=2472208551a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2472208551a5, replyNumber=0, likeNumber=139, createdTime=2021-03-19, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2472208551a5, moduleTitle=武田和IDT为强生COVID-19疫苗生产提供支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2472208551a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517843, encodeId=8006151e84349, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=官方：定期对进口物品生产经营单位工作场所开展核酸检测, objectType=article, longId=206614, objectId=c0f4206614d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0f4206614d4, replyNumber=0, likeNumber=140, createdTime=2021-02-03, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0f4206614d4, moduleTitle=官方：定期对进口物品生产经营单位工作场所开展核酸检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0f4206614d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生产

2020-05-29

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列

2022-09-13

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

CAR-T细胞生产工艺中的关键环节有哪些？如何规模化、安全稳定的生产制备？

2022-08-09

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

Contact Dermatitis：手卫生产品选什么？肥皂，酒精还是湿巾？

2022-05-05

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

丽珠V-01新冠疫苗针对老年及基础病人群保护力高达71.83%，已经生产成品约5000万剂

2022-04-08

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

亚瑟医药宣布完成数亿元人民币A轮融资，推动高端制剂研发生产及连续化生产布局，凯乘资本担任本轮融资财务顾问

2022-04-08

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

【Nature子刊】突破性方法——高效表达生物活性蛋白，快速生产大量药物！

2022-03-30

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

科学是第一生产力！这些buff可以帮助富含血小板血浆效果超级加倍

2022-02-11

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

Nature Chemical Biology ：疯狂的想法：武装CAR-T细胞，使其成为生产抗癌药物的“微型药房”

2022-01-09

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

2021年10月19日简报：本土又有少量病例感染；中国今年生产60亿剂疫苗，达到全球一半；混合接种加强针效果可能更好；

2021-10-20

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

国药集团中国生物复诺健mRNA疫苗产业化基地开工，国内又一mRNA疫苗生产线

2021-09-28

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

全国药店已超56万家，药品生产企业达7000家

2021-07-14

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

BioNTech将在新加坡、中国设厂生产mRNA新冠疫苗

2021-05-13

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

2021年5月10日全球新冠肺炎（COVID-19）疫情简报，日新增63.3万，BioNtech mRNA新冠疫苗将在国内生产和商业化

2021-05-11

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

印度是全球很大的新冠疫苗生产国，却面临严重的内部短缺

2021-05-07

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

昨日接种955万剂次！31个省（自治区、直辖市）和新疆生产建设兵团累计报告接种新冠病毒疫苗25346.3万剂次

2021-05-02

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

百济神州广州生物药生产基地正式启用，让中国患者享受国际品质抗癌药

2021-04-11

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

药明生物将接管德国制药厂，用于生产新冠疫苗等

2021-04-05

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

寡核苷酸药物未来可期，日东电工再投资超2亿美金扩大生产

2021-04-05

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

武田和IDT为强生COVID-19疫苗生产提供支持

2021-03-19

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

官方：定期对进口物品生产经营单位工作场所开展核酸检测

2021-02-03

科室
- - 订阅+
  - 更多科室
工具
服务